Zhejiang Garden Bio-chemical High-tech Co Ltd (SHE:300401) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang Garden Bio-chemical High-tech Co Ltd (300401)
Zhejiang Garden Bio-chemical High-tech Co Ltd (SHE:300401) has a market capitalization of $1.28 Billion (CN¥8.76 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #7845 globally and #1755 in its home market, demonstrating a 2.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Garden Bio-chemical High-tech Co Ltd's stock price CN¥16.11 by its total outstanding shares 543469905 (543.47 Million). Also see Zhejiang Garden Bio-chemical High-tech C assets under control for a full breakdown of the balance sheet.
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap History: 2015 to 2026
Zhejiang Garden Bio-chemical High-tech Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $862.03 Million to $1.28 Billion (7.38% CAGR). Also see 300401 operating cash flow for how efficiently the company converts equity into cash flow.
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Garden Bio-chemical High-tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Zhejiang Garden Bio-chemical High-tech C (300401) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.94x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.77x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 3.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $862.03 Million | $151.22 Million | $12.07 Million | 5.70x | 71.39x |
| 2016 | $1.15 Billion | $329.09 Million | $43.77 Million | 3.49x | 26.20x |
| 2017 | $1.33 Billion | $419.87 Million | $130.40 Million | 3.17x | 10.21x |
| 2018 | $919.31 Million | $660.22 Million | $307.41 Million | 1.39x | 2.99x |
| 2019 | $952.11 Million | $718.38 Million | $343.71 Million | 1.33x | 2.77x |
| 2020 | $1.22 Billion | $659.44 Million | $263.22 Million | 1.84x | 4.62x |
| 2021 | $1.11 Billion | $1.12 Billion | $483.77 Million | 0.99x | 2.29x |
| 2022 | $1.12 Billion | $1.42 Billion | $383.72 Million | 0.79x | 2.93x |
| 2023 | $933.82 Million | $1.09 Billion | $192.35 Million | 0.85x | 4.85x |
| 2024 | $1.17 Billion | $1.24 Billion | $309.21 Million | 0.94x | 3.77x |
Competitor Companies of 300401 by Market Capitalization
Companies near Zhejiang Garden Bio-chemical High-tech Co Ltd in the global market cap rankings as of September 19, 2026. Review 300401 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Zhejiang Garden Bio-chemical High-tech Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #619 globally with a market cap of $44.48 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #637 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Haleon plc (NYSE:HLN): Ranked #665 globally with a market cap of $41.22 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #619 | GALDERMA GROUP AG | NYSE:GALDY | $44.48 Billion | $38.15 |
| #637 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.10 |
| #665 | Haleon plc | NYSE:HLN | $41.22 Billion | $9.36 |
Zhejiang Garden Bio-chemical High-tech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap moved from $862.03 Million to $ 1.28 Billion, with a yearly change of 7.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.28 Billion | +6.55% |
| 2025 | CN¥1.20 Billion | +3.14% |
| 2024 | CN¥1.17 Billion | +24.85% |
| 2023 | CN¥933.82 Million | -16.99% |
| 2022 | CN¥1.12 Billion | +1.52% |
| 2021 | CN¥1.11 Billion | -8.87% |
| 2020 | CN¥1.22 Billion | +27.71% |
| 2019 | CN¥952.11 Million | +3.57% |
| 2018 | CN¥919.31 Million | -30.94% |
| 2017 | CN¥1.33 Billion | +16.07% |
| 2016 | CN¥1.15 Billion | +33.05% |
| 2015 | CN¥862.03 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Zhejiang Garden Bio-chemical High-tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.28 Billion USD |
| MoneyControl | $1.28 Billion USD |
| MarketWatch | $1.28 Billion USD |
| marketcap.company | $1.28 Billion USD |
| Reuters | $1.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Garden Bio-chemical High-tech Co Ltd
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more